A key development element for new molecular format biological products is to leverage the appropriate analytical tools to enhance product and process understanding throughout the development lifecycle. Here, Ian Anderson, Mostafa Zarei and Qifeng Zhang at Lonza highlight the benefits of using mass spectrometry technologies to accelerate and de-risk product and process development.

by Ian Anderson, PhD, Global Senior Principal Scientist; Mostafa Zarei, PhD, Senior Principal Scientist
You may also be interested in:
Parenteral Drug Product
Bispecific Antibody
Analytical Development
Author(s):
Qifeng Zhang
Global Senior Technical Lead
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center
Webinar (on-demand)
Enhanced GS® CHO Vector Technology for Improved Expression Control of Biotherapeutic Proteins
Many of today’s expression platforms for recombinant protein production have been optimised for the...
Used as thumbnail for Powder to Particles podcast.
Video
Small Molecule API & HPAPI Development Capacity
This video presents Lonza's capabilities, facility locations, and timelines to assist biopharma...
Webinar (on-demand)
Linking Rational Design and Material-Sparing Strategies for Enabled Intermediates and Their Drug...
The rapid development of enabled forms and formulations is crucial for tackling the challenges posed...
CHI Colmar
Presentation (on-demand)
Pioneering Capsule Innovation: Accelerating Oral and Inhalable Drug Delivery
Watch Dr. Camille Dumont and Meeta Kratz's presentation at CPHI Worldwide 2024. Explore Lonza’s...
Innovaform
R&D Blog post
Transforming drug delivery through advanced capsule innovation
Capsules represent one of the oldest pharmaceutical dosage forms, with a history dating back to...
Webinar (on-demand)
Excipients for Respiratory Delivery of Biologics
Local administration of biologic Active Pharmaceutical Ingredients to the lung via inhalation has...
Christine Lebeault
Interview
Responsible Sourcing and Manufacturing: Growing Towards a Sustainable Future with Lonza
In this article Christine Lebeault, Head of Applied Sustainability, Lonza Capsules & Health...
Spray Drying - Bend
White paper
Optimizing Spray-Dried Dispersion Processes Through Risk-Based Development
This executive summary explores a risk-based approach to process qualification, demonstrating how...
capsules in hand
Brochure
Capsugel® in-stock vegan capsule program – EMEA
Select from a variety of vegan options to satisfy your market needs quickly. Experience the many...
Couple running with dog
Webinar (on-demand)
Unlocking Pet Joint Health with Collagen - Webinar
Walking, running, playing, jumping. In this webinar, learn how you can support active owners’...
Spray Drying Bend
White paper
From Technology Selection to Final Drug Product
Many new active pharmaceutical ingredients (APIs) suffer from poor gastro-intestinal solubility in...
dry powder inhalation image
White paper
Dry Powder Vaccines to Improve Global Access and Pandemic Response
Many vaccines require cold chain storage and distribution, limiting their accessibility in...